Quanterix
Quanterix Q1 Revenues Fall 4 Percent as Instrument Sales Decline
Product and service and other revenues were both down year over year, while collaboration and grant revenues rose.
Firms including Roche and Quest have moved into the space, providing both a vote of confidence and new competition for smaller players that pioneered it.
Quanterix Q4 Revenues Down 15 Percent
The company posted revenues of $25.8 million for the quarter, down from $30.3 million in Q4 2021 and in line with the consensus Wall Street estimate.
Drug Approvals Spark Interest in Alzheimer's Plasma Markers; Utility, Applications Still Uncertain
Premium
Blood-based tests offer less invasive and less costly tools for diagnosing and monitoring Alzheimer's, but the field is still establishing which will be most informative.
Quanterix Restructuring Efforts on Track, CEO Says at JP Morgan Conference
The restructuring is to scale its operations and assays to better meet both current and anticipated demand for higher-throughput testing, its CEO said.
Aug 15, 2022
Canaccord Downgrades Quanterix From Buy to Hold
Aug 9, 2022
May 10, 2022
Quanterix Q1 Revenues up 9 Percent
Mar 1, 2022
Quanterix Q4 Revenues Rise 16 Percent
Jan 13, 2022
Quanterix Projects Q4 2021 Revenues of $29M to $31M
Aug 5, 2021
Quanterix Revenues Almost Double in Q2
May 5, 2021
Quanterix Q1 Revenues up 73 Percent
Mar 2, 2021
Quanterix Q4 Revenues Up 64 Percent
Feb 4, 2021